Ribonuclear inclusions and MBNL1 nuclear sequestration do not affect myoblast differentiation but alter gene splicing in myotonic dystrophy type 2

Neuromuscular Disorders

Volumn 19, Issue 5, 2009, Pages 335-343

  Cardani, Rosanna ^a   Baldassa, Simona ^a   Botta, Annalisa ^b   Rinaldi, Fabrizio ^b   Novelli, Giuseppe ^b   Mancinelli, Enzo ^a   Meola, Giovanni ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Alternative splicing; In vitro myoblasts differentiation; MBNL1; Myotonic dystrophy type 2; Ribonuclear inclusions

Indexed keywords

INSULIN RECEPTOR; MUSCLE PROTEIN; MUSCLEBLIND LIKE PROTEIN 1; RIBONUCLEOPROTEIN; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MYOTONIC DYSTROPHY; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA SPLICING; WESTERN BLOTTING;

ALTERNATIVE SPLICING; CELL COMPARTMENTATION; CELL DIFFERENTIATION; CELL NUCLEUS; CELLS, CULTURED; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION REGULATION; GENETIC MARKERS; GENETIC SCREENING; GENOTYPE; HUMANS; INCLUSION BODIES; MUSCLE, SKELETAL; MUTATION; MYOBLASTS, SKELETAL; MYOTONIC DYSTROPHY; REGENERATION; RIBONUCLEOTIDES; RNA-BINDING PROTEINS;

EID: 67349117382     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2009.03.002     Document Type: Article

References (51)

1. Day J.W., Ricker K., Jacobsen J.F., et al. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 60 (2003) 657-664
2. Meola G., and Moxley R.T. Myotonic dystrophy type 2 and related myotonic disorders. J Neurol 251 (2004) 1173-1182
3. Ranum L.P.W., Rasmussen P., Benzow K., Koob M., and Day J.W. Genetic mapping of a second myotonic dystrophy locus. Nat Genet 19 (1998) 196-198
4. Liquori C.L., Ricker K., Moseley M.L., et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293 (2001) 816-817
5. Ladd A.N., Charlet-B N., and Cooper T.A. The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol Cell Biol 21 (2001) 1285-1296
6. n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res 24 (1996) 4407-4414
7. Lu X., Timchenko N.A., and Timchenko L.T. Cardiac elav-type RNA-binding protein (ETR-3) binds to RNA CUG repeats expanded in myotonic dystrophy. Hum Mol Genet 8 (1999) 53-60
8. Fardaei M., Larkin K., Brook J.D., and Hamshere M.G. In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts. Nucleic Acids Res 29 (2001) 2766-2771
9. Fardaei M., Rogers M.T., Thorpe H.M., et al. Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded repeat transcripts in DM1 and DM2 cells. Hum Mol Genet 11 (2002) 805-814
10. Mankodi A., Teng-Umnuay P., Krym M., Henderson D., Swanson M., and Thornton C.A. Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2. Ann Neurol 54 (2003) 760-768
11. Brook J.D., McCurrach M.E., Harley H.G., et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68 (1992) 799-808
12. Mahadevan M., Tsilfidis C., Sabourin L., et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 30 untranslated region of the gene. Science 255 (1992) 1253-1255
13. Timchenko N.A., Cai Z.J., Welm A.L., Reddy S., Ashizawa T., and Timchenko L.T. RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J Biol Chem 276 (2001) 7820-7826
14. n expansions associated with myotonic dystrophy. EMBO J 19 (2000) 4439-4448
15. Kino Y., Oma Y., Takeshita Y., Mori D., Sasagawa N., and Ishiura S. Direct evidence that EXP/muscleblind interacts with CCUG tetranucleotide repeats. Basic Appl Myol 13 (2003) 293-298
16. Kino Y., Mori D., Oma Y., Takeshita Y., Sasagawa N., and Ishiura S. Muscleblind protein, MBNL/EXP, binds specifically to CHHG repeats. Hum Mol Genet 13 (2004) 495-507
17. Mankodi A., Urbinati C.R., Yuan Q.P., et al. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum Mol Genet 10 (2001) 2165-2170
18. Cardani R., Mancinelli E., Rotondo G., Sansone V., and Meola G. Muscleblind-like protein 1 sequestration is a molecular marker of DM1 and DM2. Eur J Histochem 50 (2006) 177-182
19. Lin L., Miller J.W., Mankodi A., et al. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum Mol Genet 15 (2006) 2087-2097
20. Ho T.H., Charlet-B N., Poulos M.G., Singh G., Swanson M.S., and Cooper T.A. Muscleblind protein regulate alternative splicing. EMBO J 23 (2004) 3103-3112
21. Dansithong W., Paul S., Comai L., and Reddy S. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor in DM1. J Biol Chem 280 (2005) 5773-5780
22. Day J.W., and Ranum L.P.W. RNA pathogenesis of the myotonic dystrophies. Neuromuscul Disord 15 (2005) 5-16
23. Ho T.H., Bundman D., Armstrong D.L., and Cooper T.A. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. Hum Mol Genet 14 (2005) 1539-1547
24. Paul S., Dansithong W., Kim D., et al. Interaction of muscleblind, CUG-BP1 and hnRNP H proteins in DM1-associated aberrant IR splicing. EMBO J 25 (2006) 4271-4283
25. Savkur R.S., Philips A.V., and Cooper T.A. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet 29 (2001) 40-47
26. Savkur R.S., Philips A.V., Cooper T.A., et al. Insulin receptor splicing alteration in myotonic dystrophy type 2. Am J Hum Genet 74 (2004) 1309-1313
27. Charlet-B N., Savkur R.S., Singh G., Philips A.V., Grice E.A., and Cooper T.A. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell 10 (2002) 45-53
28. Mankodi A., Takahashi M.P., Jiang H., et al. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol Cell 10 (2002) 35-44
29. 2+-ATPase in myotonic dystrophy type 1. Hum Mol Genet 14 (2005) 2189-2200
30. Botta A., Vallo L., Rinaldi F., et al. Gene expression analysis in myotonic dystrophy: indications for a common molecular pathogenic pathway in DM1 and DM2. Gene Expr 13 (2007) 339-351
31. Nakamori M., Kimura T., Fujimura H., Takahashi M.P., and Sakoda S. Altered mRNA splicing of dystrophin in type 1 myotonic dystrophy. Muscle Nerve 36 (2007) 251-257
32. Osborne J., and Thornton C.A. RNA-dominant diseases. Hum Mol Genet 15 (2006) R162-R169
33. Begemann G., Paricio N., Artero R., Kiss I., Perez-Alonso M., and Mlodzik M. Muscleblind, a gene required for photoreceptor differentiation in Drosophila, encodes novel nuclear Cys3His-type zinc-finger-containing proteins. Development 124 (1997) 4321-4331
34. Artero R., Prokop A., Paricio N., et al. The muscleblind gene participates in the organization of Z-bands and epidermal attachments of Drosophila muscles and is regulated by Dmef2. Dev Biol 195 (1998) 131-143
35. Furling D., Coiffier L., Mouly V., et al. Defective satellite cells in congenital myotonic dystrophy. Hum Mol Genet 10 (2001) 2079-2087
36. Furling D., Lemieux D., Taneja K., and Puymirat J. Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts. Neuromuscul Disord 11 (2001) 728-735
37. Amack J.D., Paguio A.P., and Mahadevan M.S. Cis and trans effects of the myotonic dystrophy (DM) mutation in a cell culture model. Hum Mol Genet 8 (1999) 1975-1984
38. Amack J.D., Reagan S.R., and Mahadevan M.S. Mutant DMPK 3′-UTR transcript disrupt C2C12 myogenic differentiation by compromising MyoD. J Cell Biol 159 (2002) 419-429
39. Amack J.D., and Mahadevan M.S. The myotonic dystrophy expanded CUG repeat tract is necessary but not sufficient to disrupt C2C12 myoblast differentiation. Hum Mol Genet 10 (2001) 1879-1887
40. Funk W.D., Ouellette M., and Wright W.E. Molecular biology of myogenic regulatory factors. Mol Biol Med 8 (1991) 185-195
41. Timchenko N.A., Iakova P., Cai Z.J., Smith J.R., and Timchenko L.T. Molecular basis for impaired muscle differentiation in myotonic dystrophy. Mol Cell Biol 21 (2001) 6927-6938
42. Langlois M.A., Lee N.S., Rossi J.J., and Puymirat J. Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts. Mol Ther 7 (2003) 670-680
43. Moxley 3rd RT, Meola G, Udd B, Ricker K. Report of the 84th ENMC workshop: PROMM (proximal myotonic myopathy) and other myotonic dystrophy-like syndromes: 2nd workshop. 13-15th October 2000, Loosdrecht: The Netherlands. Neuromuscul Disord 2002;12:306-17.
44. n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy. Eur J Histochem 48 (2004) 437-442
45. Moller D.E., Yokota A., Caro J.F., and Flier J.S. Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man. Mol Endocrinol 3 (1989) 1263-1269
46. Seino S., and Bell G.I. Alternative splicing of human insulin receptor messenger RNA. Biochem Biophys Res Commun 159 (1989) 312-316
47. Kanadia R.N., Johnstone K.A., Mankodi A., et al. A muscleblind knockout model for myotonic dystrophy. Science 302 (2003) 1978-1980
48. Buj-Bello A., Furling D., Tronchere H., et al. Muscle-specific alternative splicing of myotubularin-related 1 gene is impaired in DM1 muscle cells. Hum Mol Genet 11 (2002) 2297-2307
49. Houseley J.M., Wang Z., Brock G.J.R., et al. Myotonic dystrophy associated expanded CUG repeat muscleblind positive ribonuclear foci are not toxic to Drosophila. Hum Mol Genet 14 (2005) 873-883
50. Harmon E.B., Harmon M.L., Larsen T.D., Paulson A.F., and Perryman M.B. Myotonic dystrophy protein kinase is expressed in embryonic myocites and is required for myotube formation. Dev Dyn 237 (2008) 2353-2366
51. Furling D., Lam le T., Agbulut O., Butler-Browne G.S., and Morris G.E. Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophy. Am J Pathol 162 (2003) 1001-1009